Inspiration meets innovation at Brandweek, the ultimate marketing experience. Join industry luminaries, rising talent and strategic experts in Phoenix, Arizona this September 23–26 to assess challenges, develop solutions and create new pathways for growth. Register early to save.
NEW YORK Pfizer brands at Bates worth a total of $260 million are shifting to WPP Group’s J. Walter Thompson, where they will be housed in a new division called, Health@JWT, an agency representative said.
The shift, which was expected [Adweek, July 28], follows last week’s close of WPP’s deal to buy Bates parent Cordiant Communications Group.
The incoming brands, which include Benadryl, Neosporin, Rolaids and Visine, join some $200 million worth of Pfizer business already at JWT, including Listerine, Efferdent and Tucks.
WORK SMARTER - LEARN, GROW AND BE INSPIRED.
Subscribe today!
To Read the Full Story Become an Adweek+ Subscriber
Already a member? Sign in